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Assessment of quality of life, muscle strength and 
functional capacity in women with fi bromyalgia
Fábio de Souza Cardoso1, Murilo Curtolo1, Jamil Natour2, Império Lombardi Júnior3
ABSTRACT
Objective: To assess the quality of life, muscle strength and functional capacity in women with ﬁ bromyalgia (FM). 
Patients and Methods: Cross-sectional study carried out with 31 female volunteers (age range, 35 to 60 years), paired in 
two groups (16 with FM, and 15 in the control group). Both groups underwent the following assessments: one-repetition 
maximum (1RM) of knee ﬂ exors and extensors; quality of life (application of the SF-36 questionnaire); 6-minute walk 
test (6MWT); pinch strengths (tripod, pulp-to-pulp, and key) and handgrip strength. Results: A signiﬁ cant difference 
between the groups was observed in the following variables: handgrip strength; pulp-to-pulp and tripod pinch strength 
of both hands; and the 1RM test of knee ﬂ exors and extensors in both limbs (P < 0.05). Only the key pinch showed no 
statistical difference between groups for both limbs (P > 0.05). The 6MWT also showed a statistical difference between 
the groups (P < 0.01). The SF-36 showed that women with FM have reduced functional capacity, increased bodily pain, 
and worsened general health status (P < 0.05). Conclusion: The results revealed, in women with FM, a reduction in the 
following: muscle strength in the upper and lower limbs; the distance walked in the 6MWT; and quality of life.
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INTRODUCTION
Fibromyalgia (FM) is characterized by generalized chronic 
pain of still unknown cause. The pain does not have an inﬂ am-
matory origin, manifests in the musculoskeletal system, and can 
have symptoms in other systems.1 Fibromyalgia is considered 
the second most common rheumatologic disorder in the United 
States, affecting approximately four to six million North-
Americans.2-4 That population is mainly composed of women 
between 30 and 60 years, and the women:men ratio is 10:1. 
In 1990, the American College of Rheumatology (ACR) 
deﬁ ned the criteria to classify FM,5 which were validated for 
the Brazilian population in 1999 by Atallah-Haun et al.6 Those 
criteria are as follows: generalized pain in at least three of the 
four body quadrants in the last three months; and localized 
pain upon palpation in at least 11 of the 18 pre-established 
tender points.
The pathophysiology of FM includes alterations in the 
autonomic nervous function and endocrine system, genetic 
inﬂ uence, and exposure to stressors. Fibromyalgia may share 
these causal factors with other pain conditions, such as major 
depressive disorder, irritable bowel syndrome, and temporo-
mandibular disorders. Alterations in the central processing of 
sensory input and deﬁ ciencies in the endogenous inhibition of 
pain may contribute to worsen pain sensitivity and to maintain 
diffuse pain in patients with FM.7
Muscle strength is an important component of health-
related physical ﬁ tness, in addition to playing a signiﬁ cant role 
in physical development in several daily-life/sports activities.8 
It is known that patients with FM have a considerable reduc-
tion in muscle strength and performance when compared with 
individuals without FM. Mannerkorpi et al.9 have found, in 
one third of the women diagnosed with FM, lack of muscle 
strength or ﬂ exibility in their upper limbs to perform simple 
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daily activities, such as reaching for high shelves or washing 
their own hair.
The maximum capacity of a muscle or muscle group to 
generate tension against resistance is deﬁ ned as the maxi-
mum strength, which is frequently measured by use of the 
one-repetition maximum (1RM) test, a practical and low-cost 
operational method. It is deﬁ ned as the maximum amount of 
weight one can move, correctly and with no muscle compensa-
tion, for a speciﬁ c range of motion at a single time.10 That test is 
important to determine an individual’s strength, such as when 
verifying the impact of a training program, or even to assess 
the capacity for generating strength in a speciﬁ c population.
According to the American Thoracic Guidelines, the six-
minute walk test (6MWT) is safe, easy to apply, inexpensive, 
well tolerated and reﬂ ects the daily-life activities,11 being, thus, 
used to the following: to assess the patient’s physical capacity 
in general and sports activities; to assess the functional status 
of the cardiovascular and/or respiratory system of healthy indi-
viduals and of individuals in pathological conditions; to assess 
the effects of prevention and rehabilitation programs;12 and to 
identify morbidity and mortality in cardiac transplantations.13
Unﬁ t muscle has been shown to be more susceptible to 
lesion during activity,14,15 and such muscle lesion can result in 
more pain, making those individuals more sedentary and unﬁ t.
Women with FM have been shown to be physically unﬁ t and 
have reduced muscle strength in the upper limbs, but we have 
little information on the muscle strength of the lower limbs and 
on the functional capacity assessed by use of the 6MWT.
The lack of physical ﬁ tness of those patients has been well 
established in the literature. The 6MWT can be a valuable 
instrument for detecting alterations in the functional capacity, 
and, in addition, it can be correlated with muscle strength and 
quality of life. 
Thus, the present study aimed at assessing muscle strength, 
muscle functional capacity, and the quality of life of women 
with FM and healthy women, in addition to correlating the 
variables studied. 
PATIENTS AND METHODS 
This is a cross-sectional study, approved by the Committee on 
Ethics in Research of the Federal University of São Paulo 
(no 2092/08). The study selected women diagnosed with FM,16 
according to the ACR criteria, aged between 35 and 60 years, 
from the UNIFESP-EPM outpatient clinics, in the city of São 
Paulo. The control group comprised age-matched healthy 
women from the city of Santos, in the São Paulo state. The ex-
clusion criteria for both groups were as follows: presence of any 
type of inﬂ ammatory joint disease or symptomatic degenerative 
joint disease; regular practice of physical activity (at least three 
times a week); and diagnosis of depression, symptomatic lung 
and heart diseases, according to previous medical assessment.
Data were collected by two researchers, one of whom 
assessed the strength of one maximum repetition of knee 
ﬂ exion and extension, and applied the Medical Outcomes 
Study 36-Item Short-Form Health Survey (SF-36). The other 
researcher applied the 6MWT and assessed the pinch strengths 
(tripod, pulp-to-pulp, and key) and handgrip strength by use 
of the following dynamometers: Preston Pinch Gauge® (B&L 
Engineering Co, California) and Jamar® (Asimow Engineering 
Co, Los Angeles), respectively. 
To calculate the 1RM, patients were placed on a seated ﬂ exion/
extension machine, seating straight, with their vertebral column sup-
ported, their knees ﬂ exed at 90o and their popliteal fossa touching the 
edge of the seat. The patients were instructed to perform a complete 
extension of their knees up to 0o, with no postural compensations. 
During all repetitions, verbal stimuli were provided.17 For assessing 
the 1RM of knee ﬂ exion, the previously cited procedures were used, 
with the difference that the joint began extension from the 0o posi-
tion and performed a 90º ﬂ exion. Weights were added up between 
the three attempts to identify the maximum weight at which the 
patients could ﬂ ex and extend their knees.
When assessing the quality of life, the SF-36 comprised the 
following domains: physical functioning; general health per-
ceptions; mental health; role limitations due to physical health; 
vitality; role limitations due to emotional problems; social 
functioning; and bodily pain. One more question comparing 
the patient’s current and one-year-before health conditions was 
included. Each domain ranges from 0 to 100, 100 being the 
best score and 0 the worst.18
The 6MWT was performed along a long, ﬂ at, straight corridor 
with a hard surface, length marks every meter, and turnaround 
points marked with a cone. The test was always applied by the 
same properly trained examiner. The volunteers tested were ad-
vised to wear comfortable clothes and shoes suitable for walking. 
During the 10-minute rest preceding the test and at the end of 
the test, the dyspnea and fatigue levels of the lower limbs were 
measured and recorded. After the 10-minute rest, the patients were 
instructed to do their best, walking a distance of 20 meters as fast 
as possible, without running, back and forth the hallway for six 
minutes. The test was performed according to the recommenda-
tions of the American Thoracic Society.11 The test was performed 
twice at intervals of at least 30 minutes to minimize the learning 
effect, and only the second attempt was considered.
Strength was measured with instruments that had higher coef-
ﬁ cient of validity and reliability, such as the Jamar® dynamometer 
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(Asimow Engineering Co., Los Angeles, USA) and the Preston 
Pinch Gauge® dynamometer (B&L Engineering Co. California, 
USA) to measure handgrip strength and pinch strengths, respec-
tively. The patients were seated with their shoulders adduced at a 
neutral rotation and the elbow bent at a right angle.19 The forearm 
was maintained at a neutral rotation and the wrist also in a neutral 
position, a mild extension (maximum of 30º) being allowed to 
the latter.19-21 The thumb was positioned with a mild ﬂ exion of 
the interphalangeal joint, and the other ﬁ ngers not involved in 
the pinch were also maintained semiﬂ exed.19 The mean of three 
successive measurements was used.22-26
The pulp-to-pulp pinch was performed between the thumb 
and index ﬁ nger pulps. The tripod pinch (palmar pinch) in-
volved the thumb, index and middle ﬁ nger pulps. The lateral 
pinch (key pinch) involved the thumb pulp and the lateral/radial 
side of the second phalanx of the index ﬁ nger.27
Statistical analysis
The SPSS 13.0 software (SPSS, Chicago, IL, USA) was used 
for the statistical analysis. The variables were tested regard-
ing their normality by use of the Kolmogorov-Smirnov test. 
Regarding the samples considered normal, the groups were 
assessed by use of the Student t test for non-paired variables. 
RESULTS
The study sample comprised 31 women, 15 healthy and 16 
with FM. The Kolmogorov-Smirnov test showed that the FM 
group (FMG) and the control group (CG) were homogeneous 
regarding weight, height, and BMI (p > 0.05). 
In the FMG, the mean age was 53.5 ± 7.5 years (age range, 
35 to 60 years), and the mean weight was 70.6 ± 14.6 kg. The 
Table 1 
Age, weight, height, and body mass index (BMI) in FM and healthy women   
Variables
FMG (n = 16) 
(mean ± standard deviation) 
CG (n = 15)
(mean ± standard deviation) P
Age (years) 53.5 ± 7.5 54.1 ± 4.4 0.776
Weight (kg) 70.6 ± 14.6 70.6 ± 13.7 0.999
Height (m) 1.58 ± 0.05 1.60 ± 0.09 0.555
BMI (kg/cm2) 28.0 ± 4.9 27.5 ± 4.5 0.767
Table 2 
Measures of muscle strength and 6MWT in the women studied 
Variables
FMG (n = 16)
(mean ± standard deviation)
CG (n = 15)
(mean ± standard deviation) P
L. handgrip (kg/F) 20.9 ± 7.1 27.0 ± 5.4 0.011*
R. handgrip (kg/F) 22.7 ± 5.3 26.8 ± 4.5 0.028*
L. pulp-to-pulp p. (kg/F) 3.2 ± 0.8 4.2 ± 0.8 0.002*
R pulp-to-pulp p. (kg/F) 3.6 ± 0.7 4.2 ± 0.6 0.028*
L. tripod p. (kg/F) 4.2 ± 0.9 5.4 ± 1.3 0.007*
R. tripod p. (kg/F) 4.4 ± 0.7 5.4 ± 1.1 0.005*
L. key p. (kg/F) 4.5 ± 1.2 5.3 ± 0.8 0.66
R. key p. (kg/F) 5.1 ± 1.1 5.4 ± 0.9 0.454
6MWT (m) 446.7 ± 126.0 522.1 ± 47.6 0.009*
L. RM ﬂ x (kg) 10.9 ± 6.4 20.8 ± 4.6 0.000*
L. RM ext (kg) 12.3 ± 7.2 28.1 ± 6.3 0.000*
R. RM ﬂ x (kg) 14.5 ± 11.9 21.1 ± 4.1 0.049*
R. RM ext (kg) 19.1 ± 23.0 27.6 ± 6.1 0.000*
FMG: FM group; CG: control group; L: left; R: right; P: pinch; RM: repetition maximum; ﬂ x: knee ﬂ exion; ext: knee extension; 6MWT: 6-minute walk test; 
*statistically signiﬁ cant difference (P < 0.05). 
FMG: FM group; CG: control group.
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Table 3 
Domains of the SF-36 of the FMG and CG 
Domains of the SF-36
FMG (n = 16) 
(mean ± standard deviation)
CG (n = 15)
(mean ± standard deviation) P
Physical functioning 43.8 (± 20.4) 82.6 (± 13.5) 0.00*
Role limitations due to physical health 42.8 (± 41.7) 81.6 (± 31.9) 0.06
Bodily pain 35.7 (± 20.4) 78.1(± 24.07) 0.00*
General health perceptions 35.7 (± 20.4) 78.1 (± 24.07) 0.02*
Vitality 50.9 (± 25.50) 63.0 (± 17.70) 0.13
Social functioning 71.8 (± 26.92) 83.1 (± 19.14) 0.18
Role limitations due to emotional problems 58.3 (± 49.4) 55.5 (± 46.5) 0.87
Mental health 65.7(± 17.40) 74.6(± 24.26) 0.25
FMG: FM group; CG: control group. *statistically signiﬁ cant difference (P < 0.05).
Table 4 
Pearson correlation coefﬁ cients of SF-36 physical functioning and bodily pain with the following variables: 
left and right Jamar handgrip strength, left and right key pinch strength, and 6MWT   
L. Jamar R. Jamar L. key pinch strength R. key pinch strength 6-MWT
r coefﬁ cient r coefﬁ cient  Coefﬁ cient Coefﬁ cient Coefﬁ cient
Physical functioning 0.623 0.591 0.603 0.706 0.505
Bodily pain 0.245 0.452 0.604 0.667 -0.084
L: left; R: right; 6MWT: 6-minute walk test.
CG had a similar proﬁ le, with a mean age of 54.1 ± 4.4 years 
(age range, 44 to 60 years), and a mean weight of 70.6 ± 13.7 kg. 
The mean BMI values were 28.0 ± 4.9 kg/cm² in the FMG and 
27.5 ± 4.5 kg/cm² in the CG (Table 1).
A signiﬁ cant difference between the groups was ob-
served in the following parameters: handgrip strength; pulp-
to-pulp pinch strength; and tripod pinch strength for both 
hands (P < 0.05). Only the key pinch showed no statistically 
signiﬁ cant difference between the groups for both limbs 
(P > 0.05). The 1RM test of the knee ﬂ exors and extensors 
in both limbs revealed signiﬁ cant differences in muscle 
strength (P < 0.05). The 6MWT also showed a statistically 
signiﬁ cant difference in functional capacity, which was 
reduced in patients with FM (P < 0.01). The results of the 
tests are shown in Table 2.
The comparison of the two groups by use of the SF-36 
showed that the FMG women had reduced physical function-
ing, increased bodily pain, and worsened general health percep-
tions (P < 0.05). However, the other domains (role limitations 
due to physical health, vitality, social functioning, role limita-
tions due to emotional problems, and mental health) showed 
no signiﬁ cant difference (P > 0.05). These SF-36 results are 
shown in Table 3.
The Pearson correlation analysis was performed between 
all variables studied in the FMG and the most relevant results. 
The following correlation coefﬁ cient values were considered: 
r ≥ 0.70, strong correlation; r between 0.30 and 0.7, moderate 
correlation; and r between 0 and 0.3, weak correlation (Table 4).
The SF-36 physical functioning domain showed a moderate 
positive correlation with the Jamar handgrip strength, key pinch 
strength, and 6MWT, indicating that the greater the strength 
and the better the 6MWT, the greater the functional capacity.
The SF-36 bodily pain domain showed a moderate positive 
correlation with the key pinch strength.
DISCUSSION
The present study showed that women with FM, as compared 
with healthy individuals of their same age and BMI, have a 
reduced muscle strength in their upper limbs, by use of hand-
grip and pinch dynamometers, and a reduced muscle strength 
in their lower limbs, by use of 1RM measures, during knee 
ﬂ exion and extension, in both limbs. Those women also have 
function loss assessed by use of the 6MWT.
Previous studies had already shown that patients with 
FM had a considerable reduction in muscle strength and 
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performance as compared with healthy individuals.9 Women 
with FM are below average regarding physical performance 
when assessed by use of clinical tests, such as handgrip 
strength, back ﬂ exibility, 6MWT, lower limb strength, and 
isometric shoulder endurance. That reduction might be par-
tially due to chronic pain. Our study also showed a reduction 
in handgrip strength and lower limb muscle strength in women 
with FM as compared with those of healthy women.9
Nordeskiold et al.28 have also suggested that fatigue and 
pain play a signiﬁ cant role in reducing handgrip strength in 
patients with FM, which can also explain the reduction in pulp-
to-pulp and tripod pinch strength and in the muscle strength 
of knee ﬂ exors and extensors in this study.
On the other hand, the reduction in functional capacity in 
the 6MWT can be partially explained by the reduction in the 
muscle strength of lower limbs seen in this study. Other expla-
nations would be the reduction in respiratory muscle strength29 
and aerobic capacity30-32 of women with FM.
Bennett et al.33 have reported that most women with FM 
have a reduction in their aerobic capacity, and, due to a decrease 
in their sleep, they have a reduced physical activity level, which 
leads to progressive lack of ﬁ tness. That can later result in pain 
and muscle fatigue. 
Women with FM have a decrease in their anaerobic threshold, 
oxygen consumption, and maximum heart rate. That indicates that 
those women have a submaximal effort and that their ventilatory 
anaerobic threshold should be considered the best index to assess 
their physical ﬁ tness.30 In addition, it also shows that they can 
beneﬁ t from a physical ﬁ tness program,31,32 Such ﬁ ndings are in 
accordance with a worse performance in the 6MWT.
Okumus et al.34 have reported that the impact of chronic 
muscle pain on daily activities is important and that the reduction 
in muscle strength can contribute to reduce work capacity. 
Those authors have also reported that patients with FM have 
a decrease in their maximal voluntary strength and that pain 
might be partially responsible for that.
A reduction in handgrip strength has been shown in patients 
with FM as compared with individuals without that disease. 
Nordeskiold et al.28 have suggested that fatigue, pain and 
other central origin factors can inﬂ uence the muscle strength 
reduction in FM. To conﬁ rm muscle strength reduction in 
the upper limbs, we assessed the pulp-to-pulp, key and tripod 
pinch strengths. The results showed a signiﬁ cant reduction in 
the pulp-to-pulp and tripod pinch strengths, and in the handgrip 
strength in the FMG. The key pinch strength was the only vari-
able that showed no statistically signiﬁ cant difference, possibly 
because it is the strongest pinch among those assessed or be-
cause of the small sample size. This study showed a reduction 
in muscle strength and function in both upper and lower limbs 
in patients with FM.
Patients with moderate or severe pain are prone to reduce 
their physical activity, thus decreasing their muscle ﬁ tness.35
Jacobsen et al.35 have reported that individuals with FM 
have lower maximal voluntary isokinetic and isometric 
muscle strength than healthy individuals do. The reasons 
for that muscle strength reduction could be lack of motiva-
tion and pain, which have a negative effect on motor unit 
recruitment. Abnormal biopsy ﬁ ndings, poor oxygen distri-
bution, and a reduction in the muscle content of high-energy 
phosphates are other peripheral abnormalities observed in 
patients with FM.36,37
The pinch and grip strengths are related to the intrinsic and 
extrinsic muscle ﬂ exing mass of the forearm and hand, not 
necessarily with the individual’s weight and height.29 
We found a positive correlation between the hand muscle 
strength and the functional capacity of women with FM. 
Sahin et al.29 have also reported a reduction in the hand muscle 
strength in women with FM.
It is worth noting that our patients belonged in the tertiary 
health care, and, could be individuals with a greater impairment 
of muscle strength, because comorbidities, disease duration, 
and disease impact were not assessed.
Tomas-Carus et al.38 have reported a correlation between 
the improvement in lower limb muscle strength and the quality 
of life of patients with FM. Patients with FM improved their 
lower and upper limb muscle strength when submitted to an 
exercise training program.
Several studies have reported the negative impact of FM on 
quality of life.39-42 Based on that, female volunteers have been 
assessed by use of the SF-36 quality of life questionnaire to 
compare functional impairment and quality of life.44 According 
to Martinez et al.,42 the SF-36 is also efﬁ cient for assessing the 
quality of life of patients with FM, and can distinguish healthy 
individuals from those with FM.
In addition to assessing health status and physical function-
ing, the questionnaires also allow the psychological assessment 
of patients through their subscales of anxiety and depression.43 
In another study, Brazilian women with FM were compared 
with a control group regarding the effects on quality of life. 
That study, which used the SF-36 as an assessment tool, has 
concluded that the disease has a negative impact on the quality 
of life,44, 45 According to Rasol et al.,46 the comparison between 
FM and healthy women showed a signiﬁ cant difference in the 
SF-36 scores in the following domains: physical functioning; 
general health perceptions; physical role; vitality; emotional 
role; and bodily pain.
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In the present study, the SF-36 assessment showed that 
physical functioning, general health perceptions, and bodily 
pain were signiﬁ cantly different between healthy and FM indi-
viduals. The pain domain can be related to an imbalance in the 
central nervous system (CNS) mediators,47 such as serotonin. 
As previously cited, FM can be mistaken for other dis-
eases. This is due to the fact that the drop in serotonin is 
also caused by major depression. White et al.48 have reported 
that FM negatively inﬂ uences the quality of life of patients 
at productive ages. That study justiﬁ es the SF-36 ﬁ ndings, 
because the women with FM assessed showed a decrease 
in the general health status. Another important ﬁ nding was 
the decrease in the functional capacity reported by those 
women, because, in addition to pain, the symptoms of fa-
tigue and subjective weakness cause function loss, leading 
to incapacity to work, and, consequently, a drop in family 
income, which reﬂ ects in the quality of life of those indi-
viduals.48 A possible explanation for the lack of statistical 
differences in the other domains can be the sample size. 
If we had a larger number of individuals, the differences 
found could be reinforced and other differences not found 
could be evidenced.
CONCLUSION
This study shows a reduction in muscle strength in the upper and 
lower limbs of patients with FM as compared with that of healthy 
individuals of the same sex. The 6MWT conﬁ rmed that patients 
with FM walk a shorter distance than healthy individuals. In ad-
dition, some quality of life aspects are worse in patients with FM.
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